The Third Xiangya Hospital of Central South University — Changsha, Hunan

Public research footprint of The Third Xiangya Hospital of Central South University, compiled from the ClinicalTrials.gov public registry.

339

Registered studies

110

Active

Recruiting now

168

Completed

Stopped or withdrawn

Most-studied conditions

Adult Participants Requiring Tracheal Intubation Under General… · T2DM (Type 2 Diabetes Mellitus) · Pain After Abdominal Surgery · Pediatric Migraine

Recently updated registry entries

NCT07746726 — Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation and Bolus… (Not Yet Recruiting)
NCT06937944 — Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to… (Recruiting)
NCT07217301 — A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The Third Xiangya Hospital of Central South University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.